Compassionate open-label use of rituximab following a randomised clinical trial against neuromyelitis optica (RIN-2 study): B cell monitoring-based administration - ScienceDirect
Single dose of rituximab in children with steroid-dependent minimal change nephrotic syndrome
Baseline characteristics at first RTX infusion in all MS, RRMS and PMS... | Download Table
uni-ball Vision Elite BLX Infusion Rollerball Pens Fine Point Micro Tip, 0.5mm, Blue/Black, 12 Pack: Buy Online at Best Price in UAE - Amazon.ae
Frontiers | Rituximab Therapy for Primary Sjögren's Syndrome
Patient characteristics At the time of RTX infusion | Download Table
Factors Influencing Infusion-Related Reactions Following Dosing of Reference Rituximab and PF-05280586, a Rituximab Biosimilar | SpringerLink
Clinical and laboratory parameters after RTX infusion | Download Scientific Diagram
A,B) Changes in CD19+ B cell frequency before and after the first... | Download Scientific Diagram
Frontiers | Effectiveness and Safety of Rituximab in Recalcitrant Pemphigoid Diseases
Presence of anti-rituximab antibodies predicts infusion-related reactions in patients with systemic lupus erythematosus | Annals of the Rheumatic Diseases
Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor–dependent idiopathic nephrotic syndrome - ScienceDirect
Baseline characteristics at first RTX infusion in all MS, RRMS and PMS... | Download Table
CD20 before and after infusion of RTX. The '3rd day', '2nd week', '1st... | Download Scientific Diagram
Compassionate open-label use of rituximab following a randomised clinical trial against neuromyelitis optica (RIN-2 study): B cell monitoring-based administration - ScienceDirect
Comparison of Switching from the Originator Rituximab to the Biosimilar Rituximab GP2013 or Re‑Treatment with the Originator Rituximab in Patients with Active Rheumatoid Arthritis: Safety and Immunogenicity Results from a Multicenter, Randomized,
Tolerability and Safety of Switching from Rituximab to Ocrelizumab: Evaluating Factors Associated with Infusion Related Reactions - Enrique Alvarez, Kavita V. Nair, Stefan Sillau, Ian Shelton, Rebecca Seale, Sean Selva, John Corboy,
Factors Influencing Infusion-Related Reactions Following Dosing of Reference Rituximab and PF-05280586, a Rituximab Biosimilar | SpringerLink
Safety of infusing rituximab at a more rapid rate in patients with rheumatoid arthritis: results from the RATE-RA study | BMC Musculoskeletal Disorders | Full Text
Clinical courses after RTX infusion in children with refractory NS | Download Table
a) Dot-blot analysis against rituximab (RTX) or bovine serum albumin... | Download Scientific Diagram
Clinical courses after RTX infusion in children with refractory NS | Download Table
First Infusion RTX 4000 Series Official Trailer - YouTube
